Skip to content

To explore the mechanism of brain-gut axis in patients with catatonia based on the combined analysis of intestinal microbial metagenomics and serum untargeted metabolomics

To explore the mechanism of brain-gut axis in patients with catatonia based on the combined analysis of intestinal microbial metagenomics and serum untargeted metabolomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099846
Enrollment
Unknown
Registered
2025-03-31
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catatonia

Interventions

Case group (patients with tension disorder):NA
Control group (Healthy person):NA

Sponsors

Hangzhou Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Case group inclusion criteria: (1) Case group: patients who visited the psychiatric department of our hospital from March to November, 2020 (excrement and blood samples were collected before psychiatric treatment); (2) meet the diagnostic criteria of ICD-11 for Catatonia (Catatonia: 6A40), and are currently in the onset stage of catatonia; (3) aged from 18 to 60 years old (including 18 and 60 years old); (4) Han nationality; (5) body mass index (BMI) within the normal range (18.5 kg/m2 < BMI < 23.9 kg/m^2) Control group inclusion criteria: The healthy control group was recruited in a 1:1 ratio after matching the demographic and other general characteristics of the case group from the healthy population. (1) aged from 18 to 60 years old (including 18 and 60 years old); (2) Han nationality; (3) body mass index (BMI) within the normal range (18.5 kg/m2 < BMI < 23.9 kg/m^2)

Exclusion criteria

Exclusion criteria: Case group exclusion criteria: (1) Complicated with serious physical diseases, including unstable vital signs, aneurysm, pulmonary embolism, heart failure, etc.; (2) pregnant or lactating; (3) patients previously or currently diagnosed with hepatobiliary diseases, gastrointestinal diseases, endocrine and immune system diseases, metabolic diseases, blood diseases, heart, lung and nervous system diseases; (4) patients with allergic reactions and hormone therapy in the past 8 weeks or currently, or using antibiotics, antioxidants, immunosuppressants, or taking microbial agents; (5) Stressful life events within one year before the onset of the disease. Exclusion criteria for control group: (1) suffering from mental illness including but not limited to substance abuse/dependence, mental retardation, dementia, schizophrenia, bipolar disorder, depression, anxiety disorder, obsessive-compulsive disorder, personality disorder, autism, tourette syndrome, etc.; (2) pregnant or lactating; (3) patients previously or currently diagnosed with hepatobiliary diseases, gastrointestinal diseases, endocrine and immune system diseases, metabolic diseases, blood diseases, heart, lung and nervous system diseases; (4) patients with allergic reactions and hormone therapy in the past 8 weeks or currently, or using antibiotics, antioxidants, immunosuppressants, or taking microbial agents; (5) having stressful life events in the past 1 year.

Design outcomes

Primary

MeasureTime frame
Bush-Francis Catatonia Rating Scale,BFCRS;Gut Microbiota;

Countries

China

Contacts

Public ContactWang Yichao

Hangzhou Seventh People's Hospital

luofugang123123@163.com+86 134 5693 3553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026